These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 6396295

  • 1. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
    Tripathi BM, Misra NP, Dube S.
    J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
    [No Abstract] [Full Text] [Related]

  • 2. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K, Nowak A, Marlicz K, Depczyńska A, Dzieniszewski J, Milewski B, Gabryelewicz A, Kosidło S.
    Pol Tyg Lek; 1984 Nov 19; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract] [Full Text] [Related]

  • 3. A double blind evaluation of the effect of tri-potassium di-citrato bismuthate in peptic ulcer.
    Poulantzas J, Polymeropoulos PS, Papasomatious A.
    Br J Clin Pract; 1978 May 19; 32(5):147-8. PubMed ID: 352384
    [No Abstract] [Full Text] [Related]

  • 4. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982 May 19; 80():49-57. PubMed ID: 6761852
    [No Abstract] [Full Text] [Related]

  • 5. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M, Lee S, Tasman-Jones C, Nicholson G.
    N Z Med J; 1985 Mar 27; 98(775):191-2. PubMed ID: 3885084
    [Abstract] [Full Text] [Related]

  • 6. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
    Tytgat GN, van Bentem N, van Olffen G, Dekker W, Rutgeerts L, de Boer J.
    Scand J Gastroenterol Suppl; 1982 Mar 27; 80():31-8. PubMed ID: 6761850
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec 27; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of De-Nol].
    Tomecki R, Habior A, Medrzejewski W.
    Pol Tyg Lek; 1984 Sep 10; 39(37):1247-8. PubMed ID: 6390386
    [No Abstract] [Full Text] [Related]

  • 9. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR.
    Gut; 1982 Jul 10; 23(7):621-4. PubMed ID: 7044913
    [Abstract] [Full Text] [Related]

  • 10. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J, Ho J, Lam SK, Wong J, Ong GB.
    Gastroenterology; 1982 May 10; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [Abstract] [Full Text] [Related]

  • 11. Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.
    Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS.
    Drugs; 1976 Dec 10; 12(6):401-11. PubMed ID: 1001219
    [Abstract] [Full Text] [Related]

  • 12. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP, Hollanders D, Ravenscroft MM, Tweedle DE, Martin DF.
    Scand J Gastroenterol Suppl; 1982 Dec 10; 80():39-42. PubMed ID: 6761851
    [Abstract] [Full Text] [Related]

  • 13. A double-blind study of tri-potassium di-citrato bismuthate in doudenal ulcer.
    Shreeve DR.
    Postgrad Med J; 1975 Dec 10; 51(5 Suppl):33-6. PubMed ID: 781653
    [No Abstract] [Full Text] [Related]

  • 14. Update in treatment of peptic ulcer disease.
    Schubert TT.
    Mo Med; 1984 Nov 10; 81(11):723-7. PubMed ID: 6095013
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacology of peptic ulcer disease.
    Ippoliti A, Peterson W.
    Clin Gastroenterol; 1979 Jan 10; 8(1):53-67. PubMed ID: 369747
    [No Abstract] [Full Text] [Related]

  • 16. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN.
    S Afr Med J; 1986 Jul 05; 70(1):31-3. PubMed ID: 3523793
    [Abstract] [Full Text] [Related]

  • 17. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R.
    Schweiz Med Wochenschr; 1985 Jul 20; 115(29):1024-5. PubMed ID: 4048901
    [Abstract] [Full Text] [Related]

  • 18. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I, Deák G, Jávor T, Mózsik G, Nagy L, Tárnok F.
    Int J Tissue React; 1983 Jul 20; 5(4):397-401. PubMed ID: 6368445
    [Abstract] [Full Text] [Related]

  • 19. [Trithiozine and peptic ulcer. Double-blind clinical study].
    Catalano F, Brogna A, Blasi A.
    Minerva Dietol Gastroenterol; 1978 Jul 20; 24(3):197-201. PubMed ID: 368681
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind trial of cimetidine versus tri-potassium di-citrato bismuthate in chronic duodenal ulceration.
    Ward M, Pollard EJ, Cowen A.
    Med J Aust; 1981 Apr 04; 1(7):363-4. PubMed ID: 7017361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.